Valens GroWorks Corp. (CSE: VGW) together with its subsidiary is pleased to announce its engagement under a 5-year, renewable, Professional Services Agreement with Arizona-based marijuana cultivation and medicinal dispensary business MKHS.
Cannabis News
InMed's Pharmaceuticals Inc. 2017 Prospects
InMed Pharmaceuticals Inc. (CSE:IN, OTCQB:IMLFF) is a pre-clinical stage biopharmaceutical company specializing in the research, development and commercialization of cannabinoid-based therapies to treat human diseases with high unmet medical needs.
Vinergy Resources Ltd. and MJ Biopharma Announce Major Breakthrough
While the medicinal cannabis industry continues to rapidly advance and expand operations by identifying new leading edge products, leaders are turning towards the expertise and knowledge of other medical sectors, especially with influence from the biopharma sector.
Tetra Bio-Pharma Starts Phase I Clinical Study of Smoked Cannabis.
Tetra Bio-Pharma (CSE: TBP) (CSE: TBP.CN), a pharmaceutical company focused on developing and commercializing therapeutic cannabis-based products for the treatment of pain is pleased to announce that Health Canada has approved its Phase I clinical study of smoked cannabis.
Investing In A Different Kind Of Oil
In Canada, medical marijuana patients have the option to get their medication in dried form, as a concentrated oil or even fresh. Right now there are 38 approved licensed producers of medical marijuana of which only 22 produce oil. So why should this matter to Investors?
Rising India Inc. Enters the $6.5 Billion Cannabis Industry
Rising India Inc. (OTC: RSII) announced that the company is targeting opportunities in the cannabis industry. The company is in active negotiations to reach a Letter of Intent with business operators that are currently active in the cannabis industry.
Acquisitions on the Rise as Companies Increase Revenue
The global marijuana industry continues to develop at an impressive pace, driven by new developments in the field of cannabis-based pharmaceutics.
As a result, M&A activity in the market is heading toward exponential growth as well.
Mining for Marijuana in Canada
Spirit Gold (SG.v) once an exploration stage company engaged in acquiring, exploring and evaluating mineral resource has turned their attention to Marijuana. Spirit Gold Entered Into Definitive Agreement to Acquire Northern Lights Marijuana Company.
ChineseInvestors.com (CIIX) Issues Update on Recent Financial and Business Achievements
ChineseInvestors.com, Inc. (OTCQB: CIIX) this morning issued a news release highlighting some of its financial and business achievements for January 2017, as well as its plans to build on these milestones moving forward.
SinglePoint, Inc. (SING) CEO Discusses Recent Share Price Increase in Interview on MoneyTV
Full-service mobile technology and marketing provider SinglePoint, Inc. (OTC: SING) this morning was announced as a featured company on this week’s episode of MoneyTV with Donald Baillargeon.
A Tetra Bio-Pharma and IntelGenx Combine for New Drug Development
Tetra Bio-Pharma Inc. (CSE: TBP, OTC:GRPOF) and IntelGenx Corp. (TSXV:IGX, OTCQX:IGXT), annouced the signing of a binding term sheet for the development and commercialization of a drug product containing dronabinol.
Disruptive Technology: Here’s The Future $PKG $WEED $MYM $PTNYF
Ding Dong: Here’s Your Pot. In the world of new and disruptive technologies, there are a few ideas that just make a lot of sense to everyone. And sure enough, several have become overnight sensations creating unimaginable wealth (especially for early investors), while changing the landscape completely. The funny thing is, they often don’t rely on infrastructure or conventional business models at all.
Invictus MD announces binding LOI to acquire 100% of a Late Stage Applicant under Health Canada’s ACMPR
INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (CSE: IMH; OTC: IVITF; FRA: 8IS) is pleased to announce that on February 6, 2017 it had entered into a binding letter of intent (“LOI”) for an option to acquire 100% (the “Option”) of the outstanding shares of a Late Stage Applicant (the “OptionCo”) under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”) from its current shareholders (the “Vendors”).
Invictus MD (CSE:IMH, OTC:IVITF) Aquires 150 acres to Increase Production
Invictus MD Strategies Corp. (CSE:IMH, OTC:IVITF) is pleased to announce that on February 6, 2017 it has acquired 100% of the outstanding shares of a late stage applicant ("OptionCo") from its current shareholders. OptionCo has built 60,000 square feet of secured perimeter for its current production facility located on 150 acres, which is expected to have production capacity of up to 6,000 kg per annum. OptionCo has already submitted plans for additional buildings on the Property including a 30,000 square foot facility.
Invictus MD (CSE:IMH, OTC:IVITF) Acquires 150 acres to Increase Production
Invictus MD Strategies Corp. (CSE:IMH, OTC:IVITF) is pleased to announce that on February 6, 2017 it has acquired 100% of the outstanding shares from its current shareholders.
They have acquired 60,000 square feet of secured perimeter for its current production facility located on 150 acres. They have already submitted plans for additional buildings on the Property including a 30,000 square foot facility.